Skip to the page

Data / Form D filings / DELCATH SYSTEMS, INC.

DELCATH SYSTEMS, INC.: Form D filings

DELCATH SYSTEMS, INC., a biotechnology company in Queensbury, NY, filed 7 Form D notices with the SEC between 2018 and 2024. The latest, on March 26, 2024, reports $7 million sold of a $7 million offering to 17 investors.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
566 QUEENSBURY AVENUE, Queensbury, NY, 12804
Phone
(518) 743-8892
Industry
Biotechnology
Entity type
Corporation
Incorporated in
Delaware
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
872912

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Mar 26, 2024New notice$7,001,113$7,001,11317Mar 19, 2024sec.gov
Mar 31, 2023New notice$24,999,999$24,999,99917Mar 29, 2023sec.gov
Dec 16, 2022New notice$3,807,499$3,807,4997Dec 12, 2022sec.gov
Jul 22, 2022New notice$4,999,999$4,999,9996Jul 20, 2022sec.gov
Aug 27, 2019New notice$9,510,434$9,510,43433Aug 19, 2019sec.gov
Jul 25, 2019New notice$20,000,000$20,000,00031Jul 15, 2019sec.gov
Aug 3, 2018New notice$1,600,000$1,600,0001Jul 20, 2018sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Steven G. SalamonDirector
Elizabeth CzerepakDirector
Vojo J. VukovicExecutive Officer
Gerard MichelExecutive Officer, Director
Gilad AharonDirector
Roger G. StollDirector
Martha G. RookExecutive Officer
David J. HoffmanExecutive Officer
Kevin J. MuirExecutive Officer
John R. SylvesterDirector
Sandra J. PennellExecutive Officer

Other biotechnology companies in New York that filed recently

Every Form D from the week of Mar 25, 2024 · All recent filings in New York · All recent Biotechnology filings

Read from SEC EDGAR. Amount sold is what DELCATH SYSTEMS, INC. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.